Davis Jerel

Insider Reports History

Entity
Individual
Location
One Sansome Street, Suite 3630, San Francisco, CA
Signature
/s/ Venkat Ramanan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Davis Jerel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Repare Therapeutics Inc. Director Common Shares 25.1K $60.9K $2.43 Dec 29, 2022 Direct
Turnstone Biologics Corp. Director, 10%+ Owner Common Stock 2.73M Jul 25, 2023 By Versant Venture Capital V, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Common Stock 275K Jul 25, 2023 By Versant Vantage II, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Common Stock 207K Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Turnstone Biologics Corp. Director, 10%+ Owner Common Stock 90.9K Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Common Stock 82K Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Graphite Bio, Inc. Director Stock Option (right to buy) 20K Jul 19, 2023 Direct
Turnstone Biologics Corp. Director, 10%+ Owner Stock Option (Right to Buy) 12.8K Jun 3, 2024 Direct
CHINOOK THERAPEUTICS, INC. Director Common Stock 0 $39.03 Aug 11, 2023 Direct
CHINOOK THERAPEUTICS, INC. Director Common Stock 0 $39.03 Aug 11, 2023 Indirect
CHINOOK THERAPEUTICS, INC. Director Stock Option (Right to Buy) 0 $26.12 Aug 11, 2023 Direct
Repare Therapeutics Inc. Director Common Shares 0 $2.43 Dec 29, 2022 Indirect
Turnstone Biologics Corp. Director, 10%+ Owner Series A Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series A Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series A Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Turnstone Biologics Corp. Director, 10%+ Owner Series A Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Turnstone Biologics Corp. Director, 10%+ Owner Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Turnstone Biologics Corp. Director, 10%+ Owner Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series C Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series C Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series C Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Turnstone Biologics Corp. Director, 10%+ Owner Series C Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P.
Turnstone Biologics Corp. Director, 10%+ Owner Series D Preferred Stock 0 Jul 25, 2023 By Versant Vantage II, L.P.

Insider Reports Filed by Davis Jerel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TSBX Turnstone Biologics Corp. Jun 3, 2024 1 $0 4 Jul 2, 2024 Director, 10%+ Owner
TSBX Turnstone Biologics Corp. Oct 16, 2023 1 $0 4 Oct 17, 2023 Director, 10%+ Owner
KDNY CHINOOK THERAPEUTICS, INC. Aug 11, 2023 7 -$1.08M 4 Aug 11, 2023 Director
TSBX Turnstone Biologics Corp. Jul 25, 2023 26 $2.7M 4 Jul 27, 2023 Director, 10%+ Owner
TSBX Turnstone Biologics Corp. Jul 20, 2023 0 $0 3 Jul 20, 2023 Director, 10%+ Owner
GRPH Graphite Bio, Inc. Jul 19, 2023 1 $0 4 Jul 21, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. May 26, 2023 2 $0 4 May 31, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. Apr 17, 2023 1 -$6.14M 4 Apr 19, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. Mar 1, 2023 3 -$9.1M 4 Mar 3, 2023 Director
RPTX Repare Therapeutics Inc. Dec 29, 2022 12 $0 4 Jan 3, 2023 Director
KDNY CHINOOK THERAPEUTICS, INC. Dec 22, 2022 6 $0 4 Dec 27, 2022 Director
RPTX Repare Therapeutics Inc. Dec 9, 2022 1 -$4M 4 Dec 13, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. Sep 12, 2022 12 $0 4 Sep 14, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. Aug 12, 2022 6 $0 4 Aug 16, 2022 Director
GRPH Graphite Bio, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
RPTX Repare Therapeutics Inc. Jun 3, 2022 17 -$9.19M 4 Jun 7, 2022 Director, 10%+ Owner
KDNY CHINOOK THERAPEUTICS, INC. May 26, 2022 2 $0 4 May 31, 2022 Director
RPTX Repare Therapeutics Inc. May 13, 2022 1 $0 4 May 16, 2022 Director
KDNY CHINOOK THERAPEUTICS, INC. Apr 4, 2022 6 $0 4 Apr 6, 2022 Director, 10%+ Owner
KDNY CHINOOK THERAPEUTICS, INC. Jan 3, 2022 0 $0 4/A Mar 3, 2022 Director, 10%+ Owner
KDNY CHINOOK THERAPEUTICS, INC. Aug 27, 2021 3 -$11.9M 4 Aug 31, 2021 Director, 10%+ Owner
RPTX Repare Therapeutics Inc. Aug 5, 2021 6 $0 4 Aug 9, 2021 Director, 10%+ Owner
GRPH Graphite Bio, Inc. Jun 29, 2021 5 $3.06M 4 Jul 1, 2021 Director, 10%+ Owner
GRPH Graphite Bio, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 Director, 10%+ Owner
KDNY CHINOOK THERAPEUTICS, INC. Jun 4, 2021 1 $0 4 Jun 7, 2021 Director
RPTX Repare Therapeutics Inc. Jun 1, 2021 6 $0 4 Jun 3, 2021 Director, 10%+ Owner
RPTX Repare Therapeutics Inc. May 13, 2021 1 $0 4 May 14, 2021 Director
RPTX Repare Therapeutics Inc. May 5, 2021 12 $0 4 May 7, 2021 Director, 10%+ Owner
GRPH Graphite Bio, Inc. Feb 16, 2021 3 $28.8M 4 Jun 28, 2021 Director, 10%+ Owner